Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-0.29
(-1.03%)
USD |
NASDAQ |
Oct 02, 16:00
27.80
+0.01
(+0.04%)
After-Hours: 20:00
Amylyx Pharmaceuticals Net Income (Quarterly) : -43.42M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.42M |
| March 31, 2026 | -41.28M |
| December 31, 2025 | -33.00M |
| September 30, 2025 | -34.39M |
| June 30, 2025 | -41.44M |
| March 31, 2025 | -35.91M |
| December 31, 2024 | -37.55M |
| September 30, 2024 | -72.70M |
| June 30, 2024 | -72.70M |
| March 31, 2024 | -118.79M |
| December 31, 2023 | 4.731M |
| September 30, 2023 | 20.89M |
| Date | Value |
|---|---|
| June 30, 2023 | 22.07M |
| March 31, 2023 | 1.573M |
| December 31, 2022 | -42.70M |
| September 30, 2022 | -53.76M |
| June 30, 2022 | -54.07M |
| March 31, 2022 | -47.85M |
| December 31, 2021 | -28.34M |
| September 30, 2021 | -23.14M |
| June 30, 2021 | -21.92M |
| March 31, 2021 | -14.52M |
| December 31, 2020 | -8.592M |
| September 30, 2020 | 0.00 |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Pfizer Inc. | -246.00M |
| Eli Lilly & Co. | 7.095B |
| Merck & Co., Inc. | -1.337B |
| EyePoint, Inc. | -94.47M |
| Bristol Myers Squibb Co. | 3.316B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 43.42M |
| EPS Diluted (Quarterly) | -0.3905 |
| Enterprise Value | 2.849B |
| Earnings Yield | -5.16% |
| Normalized Earnings Yield | -5.156 |